Myszkowski Kenneth Allen
SEC insider (Form 3/4/5 filer). CIK 0001486672. Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2025. Located in PASADENA, CA.
Companies Myszkowski Kenneth Allen has filed insider reports for
- ARROWHEAD PHARMACEUTICALS, INC. (ARWR): Officer, Chief Financial Officer
Myszkowski Kenneth Allen
CIK: 0001486672
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (80.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 7, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect8K shares at avg. $19.70$158K - Jan 7, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect10K shares at avg. $19.69$197K - Jan 6, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect17.8K shares at avg. $19.68$350K - Jan 6, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect9.4K shares at avg. $20.10$189K - Jan 4, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
AwardDirect100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 7, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 8,000 | $19.70 | $157,600 | Direct |
| Jan 7, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 10,000 | $19.69 | $196,900 | Direct |
| Jan 6, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 17,765 | $19.68 | $349,615 | Direct |
| Jan 6, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 9,402 | $20.10 | $188,980 | Direct |
| Jan 4, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award | 100,000 | - | $0 | Direct |
1-5 of 5 transactions